Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
This grant funds initiatives aimed at enhancing clinical trial readiness for rare diseases, disorders, and syndromes.
About this program
The Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes grant supports projects that aim to improve the infrastructure and processes necessary for conducting clinical trials in the context of rare diseases. This grant is designed for researchers and organizations focused on developing strategies that facilitate the transition from preclinical research to clinical trials, ensuring that rare disease treatments can be tested effectively. By providing funding, the grant aims to address the unique challenges faced in the clinical trial landscape for rare diseases, ultimately leading to better treatment options for affected individuals. Eligible applicants include academic institutions, nonprofit organizations, and other entities engaged in rare disease research. The grant encourages collaboration among stakeholders to foster innovative approaches that enhance trial readiness. Projects funded by this grant should demonstrate a clear plan for addressing barriers to clinical trial participation and execution, thereby contributing to the overall advancement of rare disease therapies.
Eligibility
Eligible applicants include academic institutions, nonprofit organizations, and other entities engaged in rare disease research.